3,570 results match your criteria AIDS-Related Lymphomas


Letter to the editors regarding the paper: Prognostic factors in HIV-positive patients with non-Hodgkin lymphoma: a Peruvian experience.

Infect Agent Cancer 2018 11;13:39. Epub 2018 Dec 11.

1Escuela de Medicina, Facultad de Ciencias de la Salud, Universidad Peruana de Ciencias Aplicadas, 2 Alameda San Marcos Avenue, Chorrillos, 15067 Lima, Peru.

Non-Hodgkin Lymphoma (NHL) is a neoplasm associated with a group of malignancies called AIDs-Defining Malignancies (ADMs) in Human-Immunodeficiency Virus (HIV) -patients. Similar to the case of NHL in Latin America, particularly in Peru, the amount of research done on others ADMs is limited, especially in the case of Kaposi's Sarcoma (KS). Prior investigations have talked about the great potential risk that represents this illness in latin american population, but topics as prognosis factors are yet to be well defined. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13027-018-0213-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288895PMC
December 2018

AIDS-Associated Malignancies.

Cancer Treat Res 2019 ;177:1-21

Department of Dermatology, University of Texas Health Sciences Center at Houston, Houston, TX, 77030, USA.

Malignancies were one of the earliest recognized manifestations that led to the description of the acquired immune deficiency syndrome (AIDS). The majority of cancers in AIDS patients are associated with coinfection with oncogenic viruses, such as Epstein-Barr virus, human herpesvirus 8, and human papillomavirus, with resulting malignancies occurring secondary to diminished immune surveillance against viruses and virus-infected tumor cells. Over 50% of AIDS lymphomas are associated with Epstein-Barr virus (EBV) and/or HHV8 infection. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-030-03502-0_1DOI Listing
January 2019
6 Reads

A longitudinal and cross-sectional study ofEpstein-Barr virus DNA load: a possible predictor of AIDS-related lymphoma in HIV-infected patients.

Infect Dis (Lond) 2018 Oct 14:1-6. Epub 2018 Oct 14.

a Department of Internal Medicine and Infectious Diseases , Erasmus Medical Center , Rotterdam , The Netherlands.

Introduction: HIV-infected patients are more than 100-fold greater at risk for developing malignant AIDS-related lymphoma (ARL) compared to the general population. Most ARLs are EBV related. The main purpose of this study was to investigate whether a high peak EBV DNA load in HIV-infected patients is predictive of ARL, including classical Hodgkin lymphoma. Read More

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/23744235.2018.1
Publisher Site
http://dx.doi.org/10.1080/23744235.2018.1508884DOI Listing
October 2018
5 Reads

Malignancy Trends in HIV-Infected Patients Over the Past 10 Years in a Single-Center Retrospective Observational Study in the United States.

Cancer Control 2018 Jan-Dec;25(1):1073274818797955

6 Infectious Diseases and Hospital Epidemiologist, Moffitt Cancer Center and Research Institute, Tampa, FL, USA.

The introduction of antiretroviral therapy (ART) in 1995 had a dramatic impact on the morbidity and mortality of the HIV population, and subsequently, the natural history of cancer has changed. The purpose of our study was to review the prevalence of AIDS-defining malignancies and non-AIDS defining cancers (NADC), taking into consideration racial and gender variations. After the institutional review board approval, the study was conducted as a retrospective chart review of 279 HIV-infected patients who were treated at the Moffitt Cancer Center between January 1, 2000 and December 31, 2010. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1073274818797955DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6128080PMC
December 2018
9 Reads

A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.

PLoS Pathog 2018 07 27;14(7):e1007179. Epub 2018 Jul 27.

Department of Oncology in Wisconsin Institutes for Medical Research, McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.

Latent Epstein-Barr virus (EBV) infection contributes to both B-cell and epithelial-cell malignancies. However, whether lytic EBV infection also contributes to tumors is unclear, although the association between malaria infection and Burkitt lymphomas (BLs) may involve excessive lytic EBV replication. A particular variant of the viral promoter (Zp) that controls lytic EBV reactivation is over-represented, relative to its frequency in non-malignant tissue, in EBV-positive nasopharyngeal carcinomas and AIDS-related lymphomas. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.ppat.1007179DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082571PMC
July 2018
2 Reads

Incidence of Hodgkin lymphoma in HIV-positive and HIV-negative patients at a tertiary hospital in South Africa (2005 - 2016) and comparison with other African countries.

S Afr Med J 2018 Jun 26;108(7):653-567. Epub 2018 Jun 26.

Division of Haematopathology, Department of Pathology, National Health Laboratory Service and Stellenbosch University, Cape Town, South Africa.

Background: Hodgkin lymphoma (HL) is the most common non-AIDS-defining cancer in HIV-positive patients. Studies on South African (SA) populations have described the prevalence as 7 - 17% of all lymphomas, 8 - 27% of head and neck lymphomas, 9% of lymph node biopsies and 4% of HIV-related malignancies.

Objectives: To describe the incidence of HL at our centre between 2005 and 2016 by year, gender, HIV status, histological subclassification and bone marrow involvement, and compare these findings with similar SA and African studies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7196/SAMJ.2018.v108i7.12844DOI Listing
June 2018
6 Reads

Plasma EBV-load as an early biomarker and prognostic factor of HIV-related lymphomas.

Clin Infect Dis 2018 Jun 29. Epub 2018 Jun 29.

Department of Hematology, ICO- Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona.

Background: Epstein-Barr virus (EBV) has been implicated in lymphomagenesis and can be found infecting tumor cells and in plasma at lymphoma diagnosis, especially in HIV-infected patients. Our aim was to evaluate the usefulness of plasma EBV-load as biomarker and prognostic factor in HIV-related lymphomas.

Methods: EBV-load was measured by polymerase chain reaction (PCR) in plasma samples of 81 HIV-related lymphomas at different moments: within one year before lymphoma diagnosis, at diagnosis and at complete response (CR). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/cid/ciy542DOI Listing
June 2018
16 Reads

PARP1 Stabilizes CTCF Binding and Chromatin Structure To Maintain Epstein-Barr Virus Latency Type.

J Virol 2018 09 29;92(18). Epub 2018 Aug 29.

Fels Institute for Cancer Research & Molecular Biology, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA

Epstein Barr virus (EBV) is a potentially oncogenic gammaherpesvirus that establishes a chronic, latent infection in memory B cells. The EBV genome persists in infected host cells as a chromatinized episome and is subject to chromatin-mediated regulation. Binding of the host insulator protein CTCF to the EBV genome has an established role in maintaining viral latency type. Read More

View Article

Download full-text PDF

Source
http://jvi.asm.org/lookup/doi/10.1128/JVI.00755-18
Publisher Site
http://dx.doi.org/10.1128/JVI.00755-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146685PMC
September 2018
11 Reads

Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.

J Virol 2018 09 29;92(18). Epub 2018 Aug 29.

State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, People's Republic of China

Coinfection with HIV-1 and Kaposi's sarcoma-associated herpesvirus (KSHV) often leads to AIDS-related malignancies, including Kaposi's sarcoma (KS) and primary effusion lymphoma (PEL). The interaction between HIV and KSHV plays a pivotal role in the progression of these malignancies. We have previously demonstrated that, by upregulating miR-942-5p, HIV-1 viral protein R (Vpr) inhibits KSHV lytic replication by targeting IκBα to activate the NF-κB signaling (Q. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.00580-18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6146700PMC
September 2018
5 Reads

Primary Intramedullary Spinal Cord Lymphoma Presenting as a Cervical Ring-Enhancing Lesion in an AIDS Patient.

Open Forum Infect Dis 2018 Jun 4;5(6):ofy128. Epub 2018 Jun 4.

Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida.

Primary intramedullary spinal cord lymphoma (PISCL) is rare and constitutes only 1% of central nervous system lymphomas. We report a case of PISCL in a 37-year-old man with advanced AIDS. To our knowledge, only 4 cases of PISCL in the setting of HIV/AIDS have been reported in the literature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ofid/ofy128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6014371PMC
June 2018
7 Reads

Three cases of non-Hodgkin's lymphoma in HIV-infected Bulgarian patients.

Infez Med 2018 Jun;26(2):155-159

Confirmatory National Laboratory of HIV, National Institute of Infectious and Parasitic Diseases, Sofia, Bulgaria.

HIV-associated lymphoma was first classified as an AIDS-defining disease by the American Center for Disease Control and Prevention (CDC) in 1985. Non-Hodgkin's lymphomas (NHLs) are frequent malignancies in AIDS patients. The risk of NHL in the case of an underlying HIV infection is estimated to be 100 times greater than in the general population, and it increases with the progression of the retrovirus-related immunosuppression. Read More

View Article

Download full-text PDF

Source
June 2018
11 Reads

Neoplasms-associated deaths in HIV-1 infected and non-infected patients in Bahia, Brazil.

Cancer Epidemiol 2018 Jun 16;54:133-136. Epub 2018 May 16.

Universidade Federal da Bahia, Brazil.

Background: HIV-infected patients are at a higher risk to develop malignancies than general population. Although AIDS-related malignancies are a common feature of late-stage disease, patients under successful antiretroviral therapy also have an increased risk for development of non-AIDS malignancies.

Objective: To compare the frequency and characteristics of adults HIV-infected patients and general population who died of malignancies in Bahia, Brazil from January 2000 to December 2010. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2018.04.001DOI Listing
June 2018
2 Reads

Durable Complete Response of Primary CNS Lymphoma in an 80-Year-Old Patient with Retroviral Infection.

Conn Med 2017 Apr;81(4):223-226

People aging with human immunodeficiencyvirus (HIV) present a unique set of challenges for their providers. Cardiovascular, metabolic, neurodegenerative, and renal disorders, and certain cancers are more common in this cohort, which is attributed to elevated rates of inflammation. Although survival remains compromised, integration of efficacious antiretrovirals and high-dose methotrexate (HD-MTX) was shown to improve clinical results in HIV-infected patients with primary central nervous system lymphoma (PCNSL). Read More

View Article

Download full-text PDF

Source

Malignant lymphoma in the HIV-positive patient.

Eur J Haematol 2018 Jul 22;101(1):119-126. Epub 2018 May 22.

Department of Medicine I, University Hospital of Cologne, Cologne, Germany.

The introduction of combination antiretroviral therapy (cART) drastically improved performance status, immune function, and life expectancy of HIV-infected individuals. In addition, incidence of opportunistic infections and of AIDS-defining malignancies declined. Nevertheless, aggressive non-Hodgkin's lymphoma still remains the leading cause of AIDS-related deaths. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/ejh.13082
Publisher Site
http://dx.doi.org/10.1111/ejh.13082DOI Listing
July 2018
6 Reads

HIV and spinal cord disease.

Handb Clin Neurol 2018 ;152:213-227

Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States; Harvard Medical School, Boston, MA, United States. Electronic address:

The epidemiology of spinal cord disease in human immunodeficiency virus (HIV) infection is largely unknown due to a paucity of data since combination antiretroviral therapy (cART). HIV mediates spinal cord injury indirectly, by immune modulation, degeneration, or associated infections and neoplasms. The pathologies vary and range from cytotoxic necrosis to demyelination and vasculitis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-444-63849-6.00017-7DOI Listing
September 2018
15 Reads

Primary CNS lymphoma in HIV infection.

Handb Clin Neurol 2018 ;152:177-186

Department of Neuro-Oncology, Erasmus MC University Medical Center Cancer Center Daniel den Hoed, Rotterdam, The Netherlands. Electronic address:

Primary CNS lymphoma (PCNSL) has been designated an acquired immune deficiency syndrome (AIDS)-defining disease since 1983 and accounts for up to 15% of non-Hodgkin lymphomas in human immunodeficiency virus (HIV) patients. The majority of HIV patients are Epstein-Barr virus (EBV)-related. The most likely etiology is ineffective immunoregulation of EBV, inducing oncogenic protein expression, and subsequent loss of apoptosis and increased proliferation of lymphocytes. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/B97804446384960
Publisher Site
http://dx.doi.org/10.1016/B978-0-444-63849-6.00014-1DOI Listing
September 2018
15 Reads

Blood Epstein-Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma.

Med Oncol 2018 Mar 13;35(4):53. Epub 2018 Mar 13.

National Centre for HIV Malignancy, Chelsea and Westminster Hospital, 369 Fulham Road, London, SW10 9NH, UK.

In HIV-seronegative patients with advanced Hodgkin lymphoma (HL), Epstein-Barr virus (EBV) viraemia at diagnosis predicts a worse progression-free survival (PFS), independent of the International Prognostic Score. However, its role in HIV-associated HL is uncharacterised. We collected clinico-pathologic and treatment data from a prospective series of 44 HIV-associated HLs from 2000 to 2016. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-018-1099-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849636PMC
March 2018
1 Read

[Burkitt's lymphoma in a school boy with slow progression perinatally acquired HIV].

Rev Chilena Infectol 2017 Oct;34(5):507-510

Hospital General de Medellín, Colombia.

Children with perinatal human immunodeficiency virus (HIV) infection can present early or late clinical disease. HIV-associated lymphoma is a later manifestation that is associated with advanced immunosuppression (acquired immunodeficiency syndrome -AIDS). This is a case of a 9-year-old boy with recent diagnosis of HIV with Burkitt's lymphoma as first clinical manifestation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4067/S0716-10182017000500507DOI Listing
October 2017
2 Reads

Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study.

Haematologica 2018 May 8;103(5):857-864. Epub 2018 Feb 8.

University of Schleswig Holstein, Campus Kiel, Kiel, Germany.

Outcome of HIV-infected patients with AIDS-related lymphomas has improved during recent years. However, data on incidence, risk factors, and outcome of relapses in AIDS-related lymphomas after achieving complete remission are still limited. This prospective observational multicenter study includes HIV-infected patients with biopsy- or cytology-proven malignant lymphomas since 2005. Read More

View Article

Download full-text PDF

Source
http://www.haematologica.org/lookup/doi/10.3324/haematol.201
Publisher Site
http://dx.doi.org/10.3324/haematol.2017.180893DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927994PMC
May 2018
6 Reads

Safety and Preliminary Efficacy of Vorinostat With R-EPOCH in High-risk HIV-associated Non-Hodgkin's Lymphoma (AMC-075).

Clin Lymphoma Myeloma Leuk 2018 03 2;18(3):180-190.e2. Epub 2018 Feb 2.

Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

Introduction: Vorinostat (VOR), a histone deacetylase inhibitor, enhances the anti-tumor effects of rituximab (R) and cytotoxic chemotherapy, induces viral lytic expression and cell killing in Epstein-Barr virus-positive (EBV) or human herpesvirus-8-positive (HHV-8) tumors, and reactivates latent human immunodeficiency virus (HIV) for possible eradication by combination antiretroviral therapy (cART).

Patients And Methods: We performed a phase I trial of VOR given with R-based infusional EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin hydrochloride) (n = 12) and cART in aggressive HIV-associated B-cell non-Hodgkin lymphoma (NHL) in order to identify safe dosing and schedule. VOR (300 or 400 mg) was given orally on days 1 to 5 with each cycle of R-EPOCH for 10 high-risk patients with diffuse large B-cell lymphoma (1 EBV), 1 EBV/HHV-8 primary effusion lymphoma, and 1 unclassifiable NHL. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2018.01.004DOI Listing
March 2018
9 Reads

A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.

AIDS 2018 Apr;32(7):945-954

Cedars-Sinai Medical Center, Los Angeles, California, USA.

Background: Chronic immune activation is a harbinger of AIDS-associated non-Hodgkin lymphoma (AIDS-NHL), yet the underlying basis is unclear. Microbial translocation, the passage of microbial components from the gastrointestinal tract into the systemic circulation, is a source of systemic immune activation in HIV infection and may be an important contributor to chronic B-cell activation and subsequent AIDS-NHL development.

Method: We measured biomarkers of microbial translocation including bacterial receptors/antibodies, intestinal barrier proteins, and macrophage activation-associated cytokines/chemokines, in serum from 200 HIV-infected men from the Multicenter AIDS Cohort Study prior to their AIDS-NHL diagnosis (mean = 3. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAD.0000000000001771DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869109PMC
April 2018
7 Reads

[Clinical Analysis of 10 Cases of AIDS Complicated with Lymphoma].

Zhongguo Shi Yan Xue Ye Xue Za Zhi 2018 Feb;26(1):146-152

Department of Hematology, Peking Union Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China. E-mail:

Objective: To investigate the clinical features and treatment of the patients with AIDS- related lymphoma (ARL).

Methods: The clinical data, pathology, treatment and prognosis of patients with ARL were retrospectively analyzed.

Results: Among 10 cases of ARL, 9 were male and 1 was female. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7534/j.issn.1009-2137.2018.01.025DOI Listing
February 2018
2 Reads

GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus.

Med Clin (Barc) 2018 Jul 19;151(1):39.e1-39.e17. Epub 2018 Jan 19.

Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol, Institut de Recerca Josep Carreras, Universitat Autónoma de Barcelona, Badalona, Barcelona, España.

The incidence of non-Hodgkin's lymphoma and Hodgkin's lymphoma is higher in patients with HIV infection than in the general population. Following the introduction of combination antiretroviral therapy (cART), the prognostic significance of HIV-related variables has decreased, and lymphoma-related factors have become more pronounced. Currently, treatments for lymphomas in HIV-infected patients do not differ from those used in the general population. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2017.11.037DOI Listing
July 2018
26 Reads
1.252 Impact Factor

Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.

J Int AIDS Soc 2018 Jan;21(1)

Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Introduction: HIV-1 infection leads to chronic inflammation and to an increased risk of non-AIDS mortality. Our objective was to determine whether AIDS-defining events (ADEs) were associated with increased overall and cause-specific non-AIDS related mortality after antiretroviral therapy (ART) initiation.

Methods: We included HIV treatment-naïve adults from the Antiretroviral Therapy Cohort Collaboration (ART-CC) who initiated ART from 1996 to 2014. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jia2.25031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810321PMC
January 2018
22 Reads

Treatment of HIV-Associated Lymphomas: The Latest Approaches for Optimizing Outcomes.

Oncology (Williston Park) 2017 12;31(12):872-7, 884

Treatment outcomes for patients with HIV-related lymphoma have improved since the advent of combination antiretroviral therapy. Standard regimens, including intensive regimens, are being used with encouraging results in patients with diffuse large B-cell lymphoma, Burkitt lymphoma, Hodgkin lymphoma, and primary central nervous system lymphoma. Approaches to salvage therapy also parallel those used in patients without HIV infection, including autologous and allogeneic hematopoietic stem cell transplant. Read More

View Article

Download full-text PDF

Source
December 2017
4 Reads

Oral plasmablastic lymphoma as the first manifestation of AIDS.

An Bras Dermatol 2017 ;92(5 Suppl 1):110-112

Department of Oral Medicine, discipline of Oral and Maxillofacial Pathology of the Faculdade de Odontologia - Universidade de São Paulo (FO-USP) - São Paulo (SP), Brazil.

Plasmablastic lymphoma is a non-Hodgkin lymphoma characterized by its plasmacytic differentiation and predilection for the oral cavity. It is among the lymphomas most commonly associated with AIDS. This report details a case of a HIV-positive patient with a 1-month history of an exophytic mass in the gingival area of the upper left quadrant. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1590/abd1806-4841.20175417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726695PMC
March 2018
11 Reads

Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda.

Cancer Epidemiol 2018 02 14;52:70-74. Epub 2017 Dec 14.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, 20892, USA. Electronic address:

Background: Epstein-Barr virus (EBV) causes endemic Burkitt lymphoma (eBL). EBV control was improved by magnesium (Mg) supplementation in XMEN, an X-linked genetic disease associated with Mg deficiency, high circulating EBV levels (viral loads), and EBV-related lymphomas. We, therefore, investigated the relationship between Mg levels and EBV levels and eBL in Uganda. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2017.12.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785547PMC
February 2018
12 Reads

Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.

Hematol Oncol Clin North Am 2018 02;32(1):75-88

HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892-1868, USA. Electronic address:

Kaposi sarcoma herpesvirus (KSHV)-associated multicentric Castleman disease (MCD) is a rare, polyclonal lymphoproliferative disorder characterized by flares of inflammatory symptoms, edema, cytopenias, lymphadenopathy, and splenomegaly. Diagnosis requires a lymph node biopsy. Pathogenesis is related to dysregulated inflammatory cytokines, including human and viral interleukin-6. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2017.09.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726416PMC
February 2018
2 Reads

Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.

PLoS One 2017 31;12(10):e0186549. Epub 2017 Oct 31.

National Institute for Infectious Diseases L. Spallanzani, Roma, Italy.

Objectives: to compare overall survival in HIV-associated lymphoma (HIV-L) and lymphoma raising in HIV-negative population (nHIV-L) and to identify predictors of increased risk of death.

Methods: All HIV+ patients with HIV-associated lymphoma (Hodgkin lymphoma, HL; non-Hodgkin Lymphoma, NHL) observed between 1.2000 and 12. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0186549PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663375PMC
November 2017
17 Reads

Fast-Growing Subcutaneous Tumors with Lower-Extremity Edema and Rib Lesions: A Case of Non-Hodgkin's Lymphoma in an HIV-1-Infected Patient.

Am J Case Rep 2017 Oct 25;18:1135-1139. Epub 2017 Oct 25.

Department of Infectious Diseases, Capital Medical University Affiliated Beijing You An Hospital, Beijing, China (mainland).

BACKGROUND Diffuse large B-cell lymphoma (DLBCL) accounts for the large majority of AIDS-related non-Hodgkin's lymphoma (NHL). DLBCL usually arises in lymph nodes, presenting as a painless rapid swelling mass in the neck, armpit, or groin. CASE REPORT Here, we report a case of DLBCL that needed only 3 months to develop a tumor 20×15 cm in diameter in the right groin and even caused scrotum swelling and lower-extremity edema. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667585PMC
October 2017
4 Reads

Malignancies in HIV-Infected and AIDS Patients.

Adv Exp Med Biol 2017 ;1018:167-179

Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, People's Republic of China.

Currently, HIV infection and AIDS are still one of the most important epidemic diseases around the world. As early in the initial stage of HIV epidemic, the high incidence of ADCs including Kaposi sarcoma and non-Hodgkin's lymphoma was the substantial amount of disease burden of HIV infection and AIDS. With the increasing accessibility of HAART and improving medical care for HIV infection and AIDS, AIDS-related illness including ADCs has dramatically decreased. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-981-10-5765-6_10DOI Listing
April 2018
13 Reads

Advances in the treatment of newly diagnosed primary central nervous system lymphomas.

Blood Res 2017 Sep 25;52(3):159-166. Epub 2017 Sep 25.

Department of Hematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania.

Primary central nervous system lymphoma (PCNSL) is a type of highly invasive non-Hodgkin lymphoma. With a growing number of organ transplantation and immunosuppressant therapy, the incidence of PCNSL has been growing rapidly in recent years, which is attributed to the increased incidence of HIV/AIDS, a prominent risk factor for developing PCNSL. The rising rate of PCNSL incidence is the highest among the intracranial tumors. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5045/br.2017.52.3.159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641507PMC
September 2017
18 Reads

Head and Neck Lymphomas in HIV Patients: a Clinical Perspective.

Int Arch Otorhinolaryngol 2017 Oct 1;21(4):399-407. Epub 2017 Feb 1.

ENT Department, Consorci Hospital General Universitari de Valencia, Valencia, Spain.

 Because of the many HIV-related malignancies, the diagnosis and treatment of lymphoma in patients infected with human immunodeficiency virus are challenging.  Here, we review current knowledge of the pathogenesis, epidemiology, symptomatology, diagnosis, and treatment of head and neck lymphomas in HIV patients from a clinical perspective.  Although Hodgkin's lymphoma is not an AIDS-defining neoplasm, its prevalence is ten times higher in HIV patients than in the general population. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0036-1597825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5629092PMC
October 2017
9 Reads

Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.

J Virol 2017 12 30;91(24). Epub 2017 Nov 30.

Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, Washington, USA

The latency-associated nuclear antigen (LANA) of the Kaposi's sarcoma-associated herpesvirus (KSHV) performs a variety of functions to establish and maintain KSHV latency. During latency, LANA localizes to discrete punctate spots in the nucleus, where it tethers viral episomes to cellular chromatin and interacts with nuclear components to regulate cellular and viral gene expression. Using highly sensitive tyramide signal amplification, we determined that LANA localizes to the cytoplasm in different cell types undergoing the lytic cycle of replication after primary infection and after spontaneous, tetradecanoyl phorbol acetate-, or open reading frame 50 (ORF50)/replication transactivator (RTA)-induced activation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.01532-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709576PMC
December 2017
31 Reads

An intrasinusoidal extracavitary variant of primary effusion lymphoma.

Blood 2017 08;130(6):836

Weill Cornell Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2017-04-780593DOI Listing
August 2017
1 Read

Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy.

Neurology 2017 Aug 26;89(8):796-804. Epub 2017 Jul 26.

From the Department of Neurology (A.M.), Department of Ophthalmology (C.L., I.C.), and Clinical Research Unit (H.P.), Fondation Adolphe de Rothschild, Paris; Department of Infectious and Tropical Diseases (A.M., M.-G.L., M.H., G.P.) and Department of Virology (C.A.), Assistance Publique-Hôpitaux de Paris, Hôpital Tenon-Université Paris 6; and Department of Pathology (M.P., J.M.), Assistance Publique-Hôpitaux de Paris, Hôpital Lariboisière-Université Paris 7, France.

Objective: To assess the characteristics and outcomes of patients with AIDS-related primary CNS lymphoma (AR-PCNSL) in the combined antiretroviral therapy (cART) era systematically treated with high-dose methotrexate (HD-MTX).

Methods: We retrospectively analyzed (intention-to-treat analysis) 51 consecutive patients with AR-PCNSL (median age 39 years) who were diagnosed from 1996 to 2014 and treated with a median of 6 (range 1-15) infusions of HD-MTX (3 g/m) combined with cART.

Results: Median all-patients' and survivors' follow-up lasted 23 (range 0-186) and 76 (range 23-186) months, respectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004265DOI Listing
August 2017
10 Reads

Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers.

HIV AIDS (Auckl) 2017 30;9:77-93. Epub 2017 Mar 30.

Research, Innovation and Engagements, Mangosuthu University of Technology, Durban.

Alternative splicing of mRNA leads to an increase in proteome biodiversity by allowing the generation of multiple mRNAs, coding for multiple protein isoforms of various structural and functional properties from a single primary pre-mRNA transcript. The protein isoforms produced are tightly regulated in normal development but are mostly deregulated in various cancers. In HIV-infected individuals with AIDS, there is an increase in aberrant alternative splicing, resulting in an increase in HIV/AIDS-related cancers, such as Kaposi's sarcoma, non-Hodgkin's lymphoma, and cervical cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/HIV.S124911DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490432PMC
March 2017
10 Reads

Contribution of arterial spin-labelling MRI in a case with immune reconstitution inflammatory syndrome.

BMJ Case Rep 2017 Jul 6;2017. Epub 2017 Jul 6.

Department of Radiology, Kokuritsu Kokusai Iryo Center Byoin, Shinjuku-ku, Tokyo, Japan.

Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS), which occurs most often in HIV-infected patients, is an exacerbation of inflammatory reactions related to opportunistic infections as well as primary CNS malignancies both of which mostly occur in HIV-infected patients. However, differential diagnoses are challenging both clinically and radiologically. We describe a patient with CNS-IRIS due to toxoplasmosis whose C-methionine uptake suggested lymphoma but whose arterial spin-labelling MRI led to the correct diagnosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bcr-2017-219860DOI Listing
July 2017
9 Reads

Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review.

Mycoses 2017 Oct 28;60(10):626-633. Epub 2017 Jun 28.

First Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Pneumocystis jirovecii is the causative agent of Pneumocystis pneumonia (PcP), a common and often life-threatening opportunistic infection in HIV-infected patients. However, non-HIV, immunocompromised patients are at risk of PcP as well, whereas the mortality appears to be higher among these patients. Pneumocystis co-infections with other microorganisms are less frequent and only sparse reports of combined PcP and invasive pulmonary fungal infections exist in the literature, especially in the non-HIV patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/myc.12642DOI Listing
October 2017
23 Reads

Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathy.

J Immunother Cancer 2017 20;5:49. Epub 2017 Jun 20.

Division of Hematology Oncology, University of South Florida, Tampa, FL USA.

Background: We report the first case to our knowledge of a patient with relapsed/refractory classical hodgkin lymphoma and liver failure with encephalopathy along with human immunodeficiency virus/acquired immunodeficiency syndrome infection, successfully treated with nivolumab without major side effects and encouraging prolonged disease control.

Case Presentation: In December 2015, at the time of the patient's progression from his Hodgkin lymphoma after fourth line treatment, he developed persistent fevers, abdominal distension, jaundice and worsening of his liver function tests. Magnetic resonance imaging of abdomen/pelvis demonstrated hepatomegaly with innumerable new liver lesions, splenomegaly with multiple splenic nodules and several new mediastinal, intraperitoneal and retroperitoneal lymphadenopathy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0252-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477132PMC
January 2018
24 Reads

[Viral triumvirate].

Presse Med 2017 Sep 13;46(9):880-883. Epub 2017 Jun 13.

CHU de Reims, hôpital Robert-Debré, service de médecine interne, maladies infectieuses et Immunologie clinique, 51100 Reims, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lpm.2017.05.024DOI Listing
September 2017
11 Reads
1.173 Impact Factor

Bacteremia due to Gordonia polyisoprenivorans: case report and review of literature.

BMC Infect Dis 2017 06 12;17(1):419. Epub 2017 Jun 12.

Department of Clinical Laboratory, Beijing Youan Hospital, Capital Medical University, Beijing, 100069, China.

Background: Gordonia polyisoprenivorans is a ubiquitous aerobic actinomycetes bacterium that rarely cause infections in humans. Here, we report a case of G. polyisoprenivorans catheter-related bacteremia in an AIDS patient. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12879-017-2523-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468944PMC
June 2017
15 Reads

Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis.

J Virol 2017 08 27;91(16). Epub 2017 Jul 27.

Department of Molecular and Translational Medicine, University of Brescia Medical School, Brescia, Italy

AIDS-related lymphomas (ARLs) are expected to increase in the future since combined antiretroviral therapy (cART) enhances the life expectancy of HIV-1-infected (HIV) patients but does not affect the occurrence of ARLs to the same extent as that of other tumors. Lymphangiogenesis is essential in supporting growth and metastatic spreading of ARLs. HIV-1 does not infect the neoplastic B cells, but HIV-1 proteins have been hypothesized to play a key role in sustaining a prolymphangiogenic microenvironment in lymphoid organs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.00801-17DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533914PMC
August 2017
12 Reads

Endobronchial primary large B-cell Non-Hodgkin lymphoma in HIV-infected patient in the Highly Active Antiretroviral Therapy era: Description of a case report.

Respir Med Case Rep 2017 2;21:151-153. Epub 2017 May 2.

Infectious Diseases Unit, AOU Federico II, Naples, Italy.

We report an unusual case of endobronchial primary large B-cell Non Hodgkin Lymphoma in a HIV-infected patient in the course of effective Highly Active Antiretroviral Therapy (HAART). Diagnosis of large B-cell NHL was obtained by fibreoptic bronchoscopy (FOB) biopsies. Three cycles of R-CHOP chemotherapy (rituximab, vincristine, cyclophosphamide, hydroxydaunorubicin, prednisone) was performed and clinical and radiological remission was obtained after 3 cycles of therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmcr.2017.04.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435592PMC
May 2017
29 Reads

High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders.

Curr HIV Res 2017 ;15(4):258-265

Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, Torino, Italy.

Background: Lymphoproliferative disorders are frequently diagnosed in HIV-positive patients and severe infections may occur during antineoplastic treatments: the incidence and impact of such events are not well-characterized.

Objective: To describe the occurrence and mortality of incident infections in HIV-positive individuals treated for lymphoproliferative disorders.

Methods: A retrospective study in HIV-positive adults with lymphoproliferative disorders (2000- 2012) who were hospitalised to receive antineoplastic chemotherapy; antimicrobial prophylaxis with alternate day co-trimoxazole (800/160 mg) was administered to all individuals. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1570162X15666170531085838DOI Listing
May 2018
18 Reads

High frequency of identical clonal immunoglobulin DNA in pre-treatment tumor and plasma from untreated patients with HIV-associated lymphoma: prospective multicenter trial of the AIDS malignancies consortium (AMC 064).

Leuk Lymphoma 2017 12 16;58(12):2939-2942. Epub 2017 May 16.

a Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University , Baltimore , MD , USA.

Patients with HIV are at increased risk for developing B-cell lymphomas likely due in part to chronic antigen stimulation leading to clonal immunoglobulin (Ig) gene rearrangements. Next-generation sequencing (NGS)-based identification of circulating Ig clonotypes has not been well-characterized in HIV-related lymphomas. The AIDS Malignancies Consortium (AMC) enrolled 51 untreated patients with HIV-related B-cell lymphomas and analyzed paired tumor/plasma specimens for Ig clonotypes using an NGS approach (AMC064, NCT00981097). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1317095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5867902PMC
December 2017
30 Reads

Efficacy and tolerability of chemotherapy in Chinese patients with AIDS-related Burkitt lymphoma and diffuse large B-cell lymphoma: An observational study.

Sci Rep 2017 05 15;7(1):1905. Epub 2017 May 15.

Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, China.

We evaluated the efficacy and tolerability of chemotherapy in HIV-infected patients with diffuse large B-cell lymphoma (DLBCL) receiving CHOP ± R (n = 17) or Burkitt lymphoma (BL) receiving CODOX-M/IVAC ± R (n = 15). The study was conducted in Beijing Ditan Hospital from January 2009 to August 2015. The following grade 4 adverse effects were observed in BL and DLBCL patients, respectively: neutropenia (80% versus 47. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-017-02086-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432515PMC
May 2017
14 Reads